Literature DB >> 3063180

Fungal infections in cancer patients.

G P Bodey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3063180     DOI： 10.1111/j.1749-6632.1988.tb40441.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.

Authors:  H Sanati; P Belanger; R Fratti; M Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

2.  Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance.

Authors:  G D Albertson; M Niimi; R D Cannon; H F Jenkinson
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

3.  Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts.

Authors:  R A Fromtling; J N Galgiani; M A Pfaller; A Espinel-Ingroff; K F Bartizal; M S Bartlett; B A Body; C Frey; G Hall; G D Roberts
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

4.  Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.

Authors:  F Barchiesi; A L Colombo; D A McGough; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

5.  Treatment of systemic candidiasis in a neutropenic murine model using immunoglobulin G bearing liposomal amphotericin B.

Authors:  T Belay; D R Hospenthal; A L Rogers; M J Patterson
Journal:  Mycopathologia       Date:  1993-07       Impact factor: 2.574

6.  Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.

Authors:  Aslıhan Demirel; Fehmi Tabak; M Cem Ar; Bilgül Mete; Şeniz Öngören; Mücahit Yemişen; Reşat Özaras; Emre Eşkazan; Zafer Başlar; Ali Mert; Teoman Soysal; Burhan Ferhanoğlu; Yıldız Aydın; Recep Öztürk
Journal:  Turk J Haematol       Date:  2015-09       Impact factor: 1.831
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.